Trial intelligence / Profile preview

Modified vs Conventional TLIP Block in Lumbar Spine Surgery

NCT05880017Unknown

Sponsor
Ain Shams University
Start
Dec 2022
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Postoperative pain intensity expressed as A numerical rating scale (NRS) score at time zero (time of extubation). Status: unknown.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05880017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05880017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call